Viewing Study NCT00258128



Ignite Creation Date: 2024-05-05 @ 12:08 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00258128
Status: COMPLETED
Last Update Posted: 2019-04-30
First Post: 2005-11-22

Brief Title: Effect of Salicylate on Glucose Metabolism in Insulin Resistance States
Sponsor: Joslin Diabetes Center
Organization: Joslin Diabetes Center

Study Overview

Official Title: Effect of Salicylate on Glucose Metabolism in Insulin Resistance States
Status: COMPLETED
Status Verified Date: 2019-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Data supports diet induced obesity leads to activation of the IKKNF-kB inflamatory pathway and that chronic inflammation leads to insulin resistance and diabetes In rodents salicylates inhibit IKKNF-kB and may improve insulin sensitivity We will study if this is true in people
Detailed Description: Please see the following review articles on this topic

Shoelson SE Lee J Goldfine AB 2006 Inflammation in insulin resistance J Clin Invest 116 1793-1801

Goldfine AB Fonseca V and Shoelson SE 2010 Therapeutic approaches to target inflammation in type 2 diabetes Clin Chem 57 162-167

Donath MY and Shoelson SE 2011 Type 2 diabetes as an inflammatory disease Nat Rev Immunol 11 98-107

Goldfine AB and Shoelson SE 2017 Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk J Clin Invest 127 83-93

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
R01DK051729 NIH None httpsreporternihgovquickSearchR01DK051729
R37DK051729 NIH None None